Literature DB >> 8152488

Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus.

A Lorenzo1, B Razzaboni, G C Weir, B A Yankner.   

Abstract

The 37-amino-acid polypeptide amylin is the principal constituent of the amyloid deposits that form in the islets of Langerhans in patients with type-2 diabetes mellitus, but its role in the pathogenesis of this disease is unresolved. In view of the fact that the beta-amyloid protein that forms fibrils in Alzheimer's disease is toxic to neurons, we have investigated whether amylin fibrils could be toxic to pancreatic islet cells. We show here that human amylin is toxic to insulin-producing beta-cells of the adult pancreas of rats and humans. This toxicity is mediated by the fibrillar form of the amylin peptide and requires direct contact of the fibrils with the cell surface. The mechanism of cell death involves RNA and protein synthesis and is characterized by plasma membrane blebbing, chromatin condensation and DNA fragmentation, indicating that amylin induces islet cell apoptosis. These findings indicate that amylin fibril formation in the pancreas may cause islet cell dysfunction and death in type-2 diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8152488     DOI: 10.1038/368756a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  228 in total

1.  Role of Ca2+ in apoptosis evoked by human amylin in pancreatic islet beta-cells.

Authors:  J Z Bai; E L Saafi; S Zhang; G J Cooper
Journal:  Biochem J       Date:  1999-10-01       Impact factor: 3.857

Review 2.  Amyloidosis and the respiratory tract.

Authors:  J D Gillmore; P N Hawkins
Journal:  Thorax       Date:  1999-05       Impact factor: 9.139

3.  The sulfated triphenyl methane derivative acid fuchsin is a potent inhibitor of amyloid formation by human islet amyloid polypeptide and protects against the toxic effects of amyloid formation.

Authors:  Fanling Meng; Andisheh Abedini; Annette Plesner; Chris T Middleton; Kathryn J Potter; Martin T Zanni; C Bruce Verchere; Daniel P Raleigh
Journal:  J Mol Biol       Date:  2010-05-07       Impact factor: 5.469

4.  Stable and metastable states of human amylin in solution.

Authors:  Allam S Reddy; Lu Wang; Sadanand Singh; Yun L Ling; Lauren Buchanan; Martin T Zanni; James L Skinner; Juan J de Pablo
Journal:  Biophys J       Date:  2010-10-06       Impact factor: 4.033

5.  Islet amyloid polypeptide in pancreatic islets from type 1 diabetic subjects.

Authors:  Tatsuo Tomita
Journal:  Islets       Date:  2011-07-01       Impact factor: 2.694

6.  Analysis of the inhibition and remodeling of islet amyloid polypeptide amyloid fibers by flavanols.

Authors:  Ping Cao; Daniel P Raleigh
Journal:  Biochemistry       Date:  2012-03-21       Impact factor: 3.162

7.  Suppression by polycyclic compounds of the conversion of human amylin into insoluble amyloid.

Authors:  Jacqueline F Aitken; Kerry M Loomes; Barbara Konarkowska; Garth J S Cooper
Journal:  Biochem J       Date:  2003-09-15       Impact factor: 3.857

Review 8.  Islet amyloid: from fundamental biophysics to mechanisms of cytotoxicity.

Authors:  Ping Cao; Peter Marek; Harris Noor; Vadim Patsalo; Ling-Hsien Tu; Hui Wang; Andisheh Abedini; Daniel P Raleigh
Journal:  FEBS Lett       Date:  2013-02-01       Impact factor: 4.124

9.  Structured States of Disordered Proteins from Genomic Sequences.

Authors:  Agnes Toth-Petroczy; Perry Palmedo; John Ingraham; Thomas A Hopf; Bonnie Berger; Chris Sander; Debora S Marks
Journal:  Cell       Date:  2016-09-22       Impact factor: 41.582

10.  Islet amyloid polypeptide toxicity and membrane interactions.

Authors:  Ping Cao; Andisheh Abedini; Hui Wang; Ling-Hsien Tu; Xiaoxue Zhang; Ann Marie Schmidt; Daniel P Raleigh
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.